Psychiatric Drugs: The New Pharmacopoeia

Newsweeks' April 25th issue has an article that investigates the pros and cons of the psychiatric drugs on the market today to treat ADHD.

Dr. Steven Scholzmann summarize the balancing act as follows:

"We can't dismiss the dangers of these drugs—but we must also respect the dangers of the illnesses themselves. Kids with untreated ADHD lag behind kids on medication—both at school and in their emotional and physical development. They also have high rates of substance abuse. And untreated mood and anxiety disorders are major risk factors for suicide, the third leading cause of death in young people."

Newsweek article: Psychiatric Drugs: The New Pharmacopoeia